Internal Medicine, Endocrinology, Diabetes, & Metabolism · Edinburg, TX
NPI
1841381167
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2609 Michaelangelo Dr
Edinburg, TX, 78539
Phone (956) 362-5650
Groups this clinician bills Medicare through
Medicare paid, 2024
$41K
649 services
Medicare patients, 2024
283
Average age 70
Drug cost, 2024
$6.2M
13,138 prescriptions
Company payments, 2025
$132
From 4 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marcel B Twahirwa was code 99214 (office e&m - established), 304 times for 144 patients. In total Marcel B Twahirwa billed 649 services in 9 codes, and Medicare paid $41K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2017-01-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 304 | 144 | $64.67 | $20K |
| 99214 Office E&M - Established | Office | 139 | 83 | $77.63 | $11K |
| 99213 Office E&M - Established | Facility | 92 | 61 | $42.07 | $3,870 |
| 95251 Test - Miscellaneous | Facility | 26 | 21 | $25.86 | $672 |
| 99203 Office E&M - New | Facility | 22 | 22 | $58.70 | $1,291 |
| 99213 Office E&M - Established | Office | 21 | 16 | $50.25 | $1,055 |
| 99204 Office E&M - New | Facility | 20 | 20 | $93.52 | $1,870 |
| 95251 Test - Miscellaneous | Office | 13 | 11 | $23.70 | $308 |
By year: 2022 $68K for 967 services; 2023 $58K for 847 services; 2024 $41K for 649 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marcel B Twahirwa prescribed most often to Medicare patients was Levothyroxine Sodium, with 1,385 prescriptions and refills. In total Marcel B Twahirwa wrote 13,138 Medicare prescriptions that cost $6.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 1,385 | 3,709 | 405 | $14K |
| Ozempic Semaglutide | 1,173 | 1,822 | 286 | $1.7M |
| Atorvastatin Calcium Generic | 906 | 2,436 | 358 | $8,478 |
| Jardiance Empagliflozin | 603 | 1,301 | 199 | $735K |
| Metformin Hcl Generic | 533 | 1,471 | 214 | $4,384 |
| Tresiba Flextouch U-100 Insulin Degludec | 421 | 1,029 | 159 | $285K |
| Farxiga Dapagliflozin Propanediol | 403 | 785 | 123 | $416K |
| Rosuvastatin Calcium Generic | 384 | 1,007 | 150 | $5,517 |
| Pioglitazone Hcl Generic | 360 | 1,016 | 143 | $4,200 |
| Losartan Potassium Generic | 354 | 941 | 147 | $3,338 |
| Trulicity Dulaglutide | 313 | 575 | 89 | $553K |
| Lisinopril Generic | 252 | 673 | 100 | $1,803 |
| Synjardy Empagliflozin/Metformin Hcl | 246 | 561 | 71 | $311K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 211 | 521 | 85 | $28K |
| Amlodipine Besylate Generic | 209 | 540 | 95 | $1,065 |
Brand drugs: 6,459 claims; generic drugs: 5,756 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marcel B Twahirwa $132 ($132 in general payments such as food, travel and fees) from 4 companies. The largest payer was Dexcom, Inc. with $56.04.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.